ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
6,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
8,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
10,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
13,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
14,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Headache,Headaches NEC,Headaches,Nerv,N
15,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
15,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
16,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
18,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
19,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
20,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
21,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
21,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
21,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
23,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
24,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,Y
24,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
25,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
26,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
28,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
29,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
31,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
31,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,2,Headache,Headaches NEC,Headaches,Nerv,N
33,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
34,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
37,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
38,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
40,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
41,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
42,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
42,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
46,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
46,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
46,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
47,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
48,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
49,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
50,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
51,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
53,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
53,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
55,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
56,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
57,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
58,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
58,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
58,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
59,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
60,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
61,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
61,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
63,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
65,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
66,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
66,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
67,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
68,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
69,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,2,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
71,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
71,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
71,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
72,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
77,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
79,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
79,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
79,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
80,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
83,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
84,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
84,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
